Literature DB >> 20887612

Asymmetric hydrophosphylation of chiral N-phosphonyl imines provides an efficient approach to chiral α-amino phosphonates.

Parminder Kaur1, Walter Wever, Trideep Rajale, Guigen Li.   

Abstract

Chiral N-phosphonylimines were found to react with lithium phosphites to provide various substituted chiral α-amino phosphonates in excellent yields (94-97%) and diastereoselectivities (93:7-99:1). The types of bases utilized for generating the nucleophile are crucial for the effectiveness of asymmetric induction. In addition, N,N-isopropyl group on chiral N-phosphonylimine auxilliary was proven to be superior to other protecting groups in controlling diastereoselectivity. The absolute configuration was unambiguously determined by converting a chiral α-amino phosphonate into its authentic N-Cbz derivative.
© 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20887612      PMCID: PMC2951300          DOI: 10.1111/j.1747-0285.2010.01013.x

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  23 in total

1.  Phosphonopeptides, a new class of synthetic antibacterial agents.

Authors:  J G Allen; F R Atherton; M J Hall; C H Hassall; S W Holmes; R W Lambert; L J Nisbet; P S Ringrose
Journal:  Nature       Date:  1978-03-02       Impact factor: 49.962

2.  Chiral N-phosphonyl imine chemistry: an efficient asymmetric synthesis of chiral N-phosphonyl propargylamines.

Authors:  Parminder Kaur; Gaurav Shakya; Hao Sun; Yi Pan; Guigen Li
Journal:  Org Biomol Chem       Date:  2010-01-05       Impact factor: 3.876

3.  Irreversible inhibition of serine proteases - design and in vivo activity of diaryl alpha-aminophosphonate derivatives.

Authors:  M Sieńczyk; J Oleksyszyn
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

4.  Increasing permeability of phospholipid bilayer membranes to alanine with synthetic alpha-aminophosphonate carriers.

Authors:  Delia C Danila; Xinyan Wang; Heather Hubble; Igor S Antipin; Eugene Pinkhassik
Journal:  Bioorg Med Chem Lett       Date:  2008-03-06       Impact factor: 2.823

5.  Thiourea-catalyzed enantioselective hydrophosphonylation of imines: practical access to enantiomerically enriched alpha-amino phosphonic acids.

Authors:  Guy D Joly; Eric N Jacobsen
Journal:  J Am Chem Soc       Date:  2004-04-07       Impact factor: 15.419

6.  Synthesis and structure-activity relationships of antibacterial phosphonopeptides incorporating (1-aminoethyl)phosphonic acid and (aminomethyl)phosphonic acid.

Authors:  F R Atherton; C H Hassall; R W Lambert
Journal:  J Med Chem       Date:  1986-01       Impact factor: 7.446

7.  Peptide synthesis catalyzed by an antibody containing a binding site for variable amino acids.

Authors:  R Hirschmann; A B Smith; C M Taylor; P A Benkovic; S D Taylor; K M Yager; P A Sprengeler; S J Benkovic
Journal:  Science       Date:  1994-07-08       Impact factor: 47.728

8.  Synthesis, NMR characterization and in vitro antitumor evaluation of new aminophosphonic acid diesters.

Authors:  I Kraicheva; A Bogomilova; I Tsacheva; G Momekov; K Troev
Journal:  Eur J Med Chem       Date:  2009-03-24       Impact factor: 6.514

9.  Synthesis and antiviral activities of amide derivatives containing the alpha-aminophosphonate moiety.

Authors:  De-Yu Hu; Qiong-Qiong Wan; Song Yang; Bao-An Song; Pinaki S Bhadury; Lin-Hong Jin; Kai Yan; Fang Liu; Zhuo Chen; Wei Xue
Journal:  J Agric Food Chem       Date:  2008-01-10       Impact factor: 5.279

10.  Chiral N-phosphonyl imine chemistry: asymmetric aza-Henry reaction.

Authors:  Adiseshu Kattuboina; Parminder Kaur; Teng Ai; Guigen Li
Journal:  Chem Biol Drug Des       Date:  2008-03       Impact factor: 2.817

View more
  1 in total

1.  Design, synthesis, and applications of chiral N-2-phenyl-2-propyl sulfinyl imines for group-assisted purification (GAP) asymmetric synthesis.

Authors:  Suresh Pindi; Jianbin Wu; Guigen Li
Journal:  J Org Chem       Date:  2013-03-26       Impact factor: 4.354

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.